Loading chart…
LIVE
Biocon Limited, together with its subsidiaries, manufactures biotechnology products and offers research services in India, the United States, Ireland, rest of the European Union, and internationally. It operates through Generics; Biosimilars; and Contract Research, Development and Manufacturing Organization (CRDMO) segments.
Biocon Limited (BIOCON) is listed on the NSE in the Healthcare sector, Biotechnology industry. The BIOCON share price is ₹368.50 (+0.93% today), with a market capitalisation of ₹604B and a price-to-earnings (P/E) ratio of 123.7. MarketRipple tracks the BIOCON investment thesis, the ripple-chain impact of market events on Biocon Limited, and the Healthcare sector outlook.
Open
₹365.25
High
₹375.45
Low
₹365.00
Prev. Close
₹365.10
52W High
₹447.15
52W Low
₹318.40
Day range
₹365.00–₹375.45
52-week range
₹318.40–₹447.15
Volume
3.0M
P/E
123.7
ROE
1.0%
D/E
0.45
Margin
2.6%
Biocon Limited (NSE: BIOCON) is currently trading at ₹368.50 (+0.93%).
Biocon Limited's market capitalization is ₹604B.
Biocon Limited's price-to-earnings (P/E) ratio is 123.7.
Biocon Limited operates in the Healthcare sector (Biotechnology).
Analyst consensus on Biocon Limited currently reads positive, based on 19 analysts covering the stock. This is third-party analyst data, not a MarketRipple recommendation.